Summary
Cellix's goal is to launch the INISH MINI-BAR; a new low-cost, portable, rapid diagnostic device for fast and reliable detection of bacteria in beer directly from the tap enabling easy continuous monitoring of beer for contamination. At present, breweries have no control over the quality of draught beer delivered to their customers as the existing ATP luminometer test is too time-consuming to be adopted as part of routine quality control programs. Data now show that revenues of beer sales and profits for breweries are directly correlated to the quality of beer delivered to the customer with revenues affected by as much as 10%. With a market value of ~€209 billion, it is easy to understand why quality control of beer at the tap is now a high priority for breweries.
Target customers are breweries such as Heineken, Carlsberg and AB InBev where the end-users are the breweries’ trade operators, whose job it is to service and clean beer taps and lines in bars and restaurants. INISH MINI-BAR has a cost per test of €7 for the ATP luminometer test. This can potentially save breweries ~€1.9M per region enabling them to implement a rigorous quality control program which can boost their profits. This product development enables Cellix to open up a new market in field based testing. Cellix’s aim is to scale up revenue to ~€28M by Year 5 of market introduction resulting in the creation of an additional 82 jobs.
Target customers are breweries such as Heineken, Carlsberg and AB InBev where the end-users are the breweries’ trade operators, whose job it is to service and clean beer taps and lines in bars and restaurants. INISH MINI-BAR has a cost per test of €7 for the ATP luminometer test. This can potentially save breweries ~€1.9M per region enabling them to implement a rigorous quality control program which can boost their profits. This product development enables Cellix to open up a new market in field based testing. Cellix’s aim is to scale up revenue to ~€28M by Year 5 of market introduction resulting in the creation of an additional 82 jobs.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: | https://cordis.europa.eu/project/id/755731 |
Start date: | 01-01-2017 |
End date: | 31-12-2018 |
Total budget - Public funding: | 1 602 413,75 Euro - 1 121 689,00 Euro |
Cordis data
Original description
Cellix's goal is to launch the INISH MINI-BAR; a new low-cost, portable, rapid diagnostic device for fast and reliable detection of bacteria in beer directly from the tap enabling easy continuous monitoring of beer for contamination. At present, breweries have no control over the quality of draught beer delivered to their customers as the existing ATP luminometer test is too time-consuming to be adopted as part of routine quality control programs. Data now show that revenues of beer sales and profits for breweries are directly correlated to the quality of beer delivered to the customer with revenues affected by as much as 10%. With a market value of ~€209 billion, it is easy to understand why quality control of beer at the tap is now a high priority for breweries.Target customers are breweries such as Heineken, Carlsberg and AB InBev where the end-users are the breweries’ trade operators, whose job it is to service and clean beer taps and lines in bars and restaurants. INISH MINI-BAR has a cost per test of €7 for the ATP luminometer test. This can potentially save breweries ~€1.9M per region enabling them to implement a rigorous quality control program which can boost their profits. This product development enables Cellix to open up a new market in field based testing. Cellix’s aim is to scale up revenue to ~€28M by Year 5 of market introduction resulting in the creation of an additional 82 jobs.
Status
CLOSEDCall topic
SMEInst-07-2016-2017Update Date
27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
H2020-EU.3.2. SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy
H2020-EU.3.2.4. Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy